Remote Ischemic Conditioning Paired With Endovascular Treatment for Acute Ischemic Stroke (REVISE-1)

Recruiting

Phase 1 Results N/A

Summary of Purpose

Currently, early reperfusion is considered as the most effective therapy for the treatment of acute ischemic stroke (AIS). Over the past 20 years, intravenous tissue plasminogen activator (IV tPA) has been demonstrated to be the only effective therapy for AIS. More recently, several large randomized clinical trials have concluded the superiority of endovascular mechanical thrombectomy for AIS. Furthermore, with...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 September 2017.

7 Jul 2017 26 Jun 2017 17 Sep 2017 17 Dec 2017 1 Sep 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts